Skip to main content

Median Technologies: Financial Communications Schedule for the First Half of 2025

Regulatory News:

Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible), announces the publication date for its 2024 results:

 

Publication

   

Date

 

2024 results

   

April 29, 2025*

*Distribution after the close of trading

About Median Technologies: Pioneering innovative imaging services and Software as Medical Devices, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as medical devices (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.65
-3.38 (-1.52%)
AAPL  260.59
-2.18 (-0.83%)
AMD  237.79
-0.24 (-0.10%)
BAC  51.31
-0.21 (-0.40%)
GOOG  256.23
+4.89 (1.95%)
META  734.99
+1.72 (0.23%)
MSFT  522.18
+4.52 (0.87%)
NVDA  182.34
+1.18 (0.65%)
ORCL  276.76
+1.61 (0.59%)
TSLA  441.10
-1.50 (-0.34%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.